It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Clostridioides difficile, a cause of healthcare-associated infections, poses a significant global health threat. This multi-institutional retrospective study focuses on epidemic dynamics, emphasizing minor and toxin-negative clinical isolates through high-resolution genotyping. The genotype of the C. difficile clinical isolates during 2005 to 2022 was gathered from 14 hospitals across Japan (N = 982). The total number of unique genotypes was 294. Some genotypes were identified in every hospital (cross-regional genotypes), while others were unique to a specific hospital or those in close geographic proximity (region-specific genotypes). Notably, a hospital located in a sparsely populated prefecture exhibited the highest prevalence of region-specific genotypes. The isolation rate of cross-regional genotypes positively correlated with the human mobility flow. A 6-month interval analysis at a university hospital from 2019 to 2021 revealed a temporal transition of the genotype dominance. The frequent isolation of identical genotypes over a brief timeframe did not always align with the current criteria for defining nosocomial outbreaks. This study highlights the presence of diverse indigenous C. difficile strains in regional environments. The cross-regional strains may have a higher competency to spread in the human community. The longitudinal analysis underscores the need for further investigation into potential nosocomial spread.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Osaka Medical and Pharmaceutical University, Department of Microbiology and Infection Control, Faculty of Pharmacy, Takatsuki, Japan (GRID:grid.444883.7) (ISNI:0000 0001 2109 9431)
2 National Hospital Organization Nagoya Medical Center, Department of Clinical Laboratory, Nagoya, Japan (GRID:grid.410840.9) (ISNI:0000 0004 0378 7902)
3 Osaka Institute of Public Health, Division of Microbiology, Osaka, Japan (GRID:grid.416993.0) (ISNI:0000 0004 0629 2067)
4 Osaka Medical and Pharmaceutical University Hospital, Infection Control Center, Takatsuki City, Japan (GRID:grid.444883.7) (ISNI:0000 0001 2109 9431); Osaka Medical and Pharmaceutical University Hospital, Department of Central Clinical Laboratory, Takatsuki City, Japan (GRID:grid.444883.7) (ISNI:0000 0001 2109 9431)
5 Osaka Medical and Pharmaceutical University Hospital, Department of Central Clinical Laboratory, Takatsuki City, Japan (GRID:grid.444883.7) (ISNI:0000 0001 2109 9431); Osaka Medical and Pharmaceutical University, Department of Microbiology and Infection Control, Faculty of Medicine, Takatsuki City, Japan (GRID:grid.444883.7) (ISNI:0000 0001 2109 9431)
6 Osaka Medical and Pharmaceutical University Hospital, Infection Control Center, Takatsuki City, Japan (GRID:grid.444883.7) (ISNI:0000 0001 2109 9431)
7 Osaka Medical and Pharmaceutical University Hospital, Infection Control Center, Takatsuki City, Japan (GRID:grid.444883.7) (ISNI:0000 0001 2109 9431); Osaka Medical and Pharmaceutical University, Department of Microbiology and Infection Control, Faculty of Medicine, Takatsuki City, Japan (GRID:grid.444883.7) (ISNI:0000 0001 2109 9431)
8 Osaka Medical and Pharmaceutical University, Department of Microbiology and Infection Control, Faculty of Pharmacy, Takatsuki, Japan (GRID:grid.444883.7) (ISNI:0000 0001 2109 9431); Osaka Medical and Pharmaceutical University Hospital, Infection Control Center, Takatsuki City, Japan (GRID:grid.444883.7) (ISNI:0000 0001 2109 9431); Osaka Medical and Pharmaceutical University, Department of Microbiology and Infection Control, Faculty of Medicine, Takatsuki City, Japan (GRID:grid.444883.7) (ISNI:0000 0001 2109 9431)
9 International University of Health and Welfare, Department of Medical Technology and Science, Faculty of Fukuoka Health Care, Okawa, Japan (GRID:grid.411731.1) (ISNI:0000 0004 0531 3030)
10 Osaka Metropolitan University Graduate School of Medicine, Department of Infection Control Science, Osaka, Japan (GRID:grid.411731.1)
11 Hospital of the University Occupational and Environmental Health, Fukuoka, Japan (GRID:grid.271052.3) (ISNI:0000 0004 0374 5913)
12 Hokkaido University Hospital, Division of Laboratory and Transfusion Medicine, Sapporo, Japan (GRID:grid.412167.7) (ISNI:0000 0004 0378 6088)